- Home
- EGY vs MLAB Comparison
EGY vs MLAB Comparison
Compare EGY & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EGY
- MLAB
- Stock Information
- Founded
- EGY 1985
- MLAB 1982
- Country
- EGY United States
- MLAB United States
- Employees
- EGY N/A
- MLAB N/A
- Industry
- EGY Oil & Gas Production
- MLAB Industrial Machinery/Components
- Sector
- EGY Energy
- MLAB Industrials
- Exchange
- EGY Nasdaq
- MLAB Nasdaq
- Market Cap
- EGY 399.3M
- MLAB 341.1M
- IPO Year
- EGY N/A
- MLAB N/A
- Fundamental
- Price
- EGY $3.87
- MLAB $76.71
- Analyst Decision
- EGY
- MLAB Hold
- Analyst Count
- EGY 0
- MLAB 1
- Target Price
- EGY N/A
- MLAB $67.00
- AVG Volume (30 Days)
- EGY 667.9K
- MLAB 88.5K
- Earning Date
- EGY 11-10-2025
- MLAB 11-06-2025
- Dividend Yield
- EGY 6.46%
- MLAB 0.83%
- EPS Growth
- EGY N/A
- MLAB N/A
- EPS
- EGY 0.37
- MLAB N/A
- Revenue
- EGY $469,277,000.00
- MLAB $242,351,000.00
- Revenue This Year
- EGY N/A
- MLAB $5.38
- Revenue Next Year
- EGY $23.20
- MLAB $5.25
- P/E Ratio
- EGY $10.51
- MLAB N/A
- Revenue Growth
- EGY N/A
- MLAB 8.33
- 52 Week Low
- EGY $3.00
- MLAB $55.45
- 52 Week High
- EGY $5.88
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- EGY 48.92
- MLAB 56.44
- Support Level
- EGY $3.79
- MLAB $76.85
- Resistance Level
- EGY $4.00
- MLAB $80.14
- Average True Range (ATR)
- EGY 0.12
- MLAB 3.61
- MACD
- EGY 0.01
- MLAB 0.45
- Stochastic Oscillator
- EGY 65.79
- MLAB 71.10
About EGY VAALCO Energy Inc.
VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea, and Cote d'Ivoire. The company generates maximum revenue from the Gabon segment.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.